Author

Sharif Rahmy

University of Notre DameORCID 0000-0002-7825-7186Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Approach:microscopy & imaging analysis· 1 Organism:mouse· 1 Assay:scRNA-seq· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Ariana ArceiD· 1 shared Guoqiang LiuiD· 1 shared Jing Hui YangiD· 1 shared Jun WaniD· 1 shared Liang Cheng CiD· 1 shared Lin JiaiD· 1 shared Loan DuongiD· 1 shared Shan Feng· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ariana ArceORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CDH3 as a Novel Therapeutic Target in Basal-like Double-Negative Prostate Cancer

Guoqiang Liu, Shiyu Wang, Loan Duong, Ziyu Zeng, Jing Hui Yang, Yun Zhao, Sharif Rahmy, Shan Feng, Ariana Arce, Lin Jia, Jun Wan, Liang Cheng C, Xuemin Lu, Xin Lü

This study identifies CDH3 as a key driver of basal-like prostate cancer and shows that CDH3-targeted therapies like ADCs and CAR T cells are effective in preclinical models.

bioRxiv · Nov 18, 2025 · PreprintCancer Biology